|
- Biopharma Healthcare Solutions | Grifols
Grifols is a leading global healthcare company Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives
- Company | Grifols
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries
- What we do | Grifols
As Grifols grew into a global plasma leader over the last 50 years, the company became increasingly known for its industrial excellence, with advanced machinery, robotics and equipment for highly sophisticated and efficient manufacturing operations
- Our history - Grifols. com
The founding of Laboratorios Grifols by Grifols i Roig and his sons, Josep Antoni Grifols i Lucas, a hematologist; and Víctor Grifols i Lucas, a chemist and pharmacist, begins an era of business dedicated to clinical analysis and the preparation of freeze-dried plasma
- Careers | Grifols
At Grifols, we are continually inspired and motivated to develop and provide plasma-derived medicines as well as other biopharmaceuticals and healthcare solutions to enhance people’s health and well-being
- USA - Grifols. com
Based in Los Angeles, we cover the U S market where we offer a comprehensive portfolio of Grifols products and services The company is one of the largest producers of life-saving plasma medicines and other innovative biopharmaceutical solutions in the world
- About Grifols - Diagnostic
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world The company develops, produces, and provides innovative healthcare services and solutions in more than 110 countries
- Excellence in Developing Plasma Therapeutics | Grifols
Grifols researches, develops, produces and markets plasma-derived medicines and other innovative biopharmaceutical solutions to treat patients with chronic, rare and prevalent conditions that can be life-threatening
|
|
|